Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
ICD-10 E05.11 is a billable code used to indicate a diagnosis of thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm.
Thyrotoxicosis with a toxic single thyroid nodule is a condition characterized by excessive thyroid hormone production due to a hyperfunctioning nodule within the thyroid gland. This condition can lead to a thyrotoxic crisis or storm, a life-threatening exacerbation of hyperthyroidism that requires immediate medical attention. Patients may present with symptoms such as palpitations, anxiety, tremors, heat intolerance, weight loss, and increased appetite. In severe cases, symptoms can escalate to fever, tachycardia, and altered mental status. The diagnosis is typically confirmed through thyroid function tests, which reveal elevated levels of free thyroxine (FT4) and suppressed thyroid-stimulating hormone (TSH). Imaging studies, such as a thyroid scan, may be utilized to identify the toxic nodule. Management often involves antithyroid medications, beta-blockers for symptomatic relief, and in some cases, radioactive iodine therapy or surgery. Understanding the nuances of this condition is crucial for accurate coding and appropriate patient management.
Thorough documentation of thyroid function tests, imaging results, and treatment plans.
Patients presenting with symptoms of hyperthyroidism, requiring evaluation of thyroid nodules.
Endocrinologists must ensure that all relevant lab results and imaging studies are included in the patient's record.
Detailed history and physical examination findings, including vital signs and symptom assessment.
Management of acute thyrotoxic crisis in hospitalized patients.
Internal medicine physicians should document the acute presentation and any interventions performed.
Used to assess thyroid function in patients suspected of thyrotoxicosis.
Document the reason for the test and any relevant clinical findings.
Endocrinologists should ensure that TSH levels are interpreted in the context of FT4 results.
Key symptoms include fever, tachycardia, altered mental status, and severe agitation. Patients may also experience gastrointestinal symptoms such as nausea and vomiting.
